The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 24, 2018

Filed:

Sep. 29, 2015
Applicant:

Inter-med, Inc., Racine, WI (US);

Inventors:

Gary Pond, Milwaukee, WI (US);

John Baeten, Oak Creek, WI (US);

Assignee:

Inter-Med, Inc., Racine, WI (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); A61B 5/00 (2006.01); A61B 19/02 (2006.01); A61K 49/00 (2006.01); A61B 50/33 (2016.01);
U.S. Cl.
CPC ...
G01N 33/57407 (2013.01); A61B 5/0071 (2013.01); A61B 5/0088 (2013.01); A61B 50/33 (2016.02); A61K 49/0056 (2013.01); A61B 2562/0233 (2013.01); G01N 2333/42 (2013.01);
Abstract

Methods and kits for assessing the presence of, and for detecting cancer, notably oral cancer, are disclosed. Such methods and kits use one or more lectins operably linked to a fluorophore, wherein the lectin binds differentially to cancerous and non-cancerous tissues, and wherein the fluorophore facilitates visualizing the differential binding. The lectins are applied to the oral mucosa of a subject, the fluorophore is exposed to light, and cancerous regions of the mucosa are visualized. In certain embodiments, the lectin specifically binds to one or more of a β-galactoside, an α- or β-N-acetylglucosamine, or a sialic acid moiety.


Find Patent Forward Citations

Loading…